Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From 10Q regarding ITC

An Initial Determination was rendered on September 6, 2013 finding that none of the remaining Respondents had infringed the ‘336 patent. We filed a petition for review of the Initial Determination with the full ITC on September 23, 2013. We expect to learn within 45 days of the date of the Initial Determination if the petition for review will be granted. If granted, the ITC could potentially reconsider the finding of noninfringement. If we prevail in a review by the full ITC such that the ‘336 is found to be infringed, then the target date in the ITC proceeding in which the ITC could potentially issue an importation ban on infringing products, is January 6, 2014. All of the district court actions against the new parties (i.e., all respondents other than Acer and HTC) that have not previously settled are currently stayed pending resolution of the 853 Investigation. p.19

Share
New Message
Please login to post a reply